Technical Analysis for SILO - Silo Pharma, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
200 DMA Support | Bullish | -3.89% | |
Bullish Engulfing | Bullish | -3.89% | |
Outside Day | Range Expansion | -3.89% | |
Lower Bollinger Band Touch | Weakness | -3.89% | |
NR7 | Range Contraction | 1.17% | |
NR7-2 | Range Contraction | 1.17% | |
Narrow Range Bar | Range Contraction | 1.17% | |
Below Lower BB | Weakness | 1.17% | |
Lower Bollinger Band Touch | Weakness | 1.17% | |
Fell Below 50 DMA | Bearish | -1.14% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 2 hours ago |
Down 3% | about 2 hours ago |
Fell Below Lower Bollinger Band | about 2 hours ago |
Gap Down Partially Closed | about 3 hours ago |
Gapped Down (Partial) | about 3 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/28/2024
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University of Maryland, The Regents of the University of California, and Columbia University. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Keywords: Alzheimer's Disease Parkinson's Disease Depression Post Traumatic Stress Disorder Rare Neurological Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Alzheimer's Disease Parkinson's Disease Depression Post Traumatic Stress Disorder Rare Neurological Disorders
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.05 |
52 Week Low | 1.2162 |
Average Volume | 238,673 |
200-Day Moving Average | 1.70 |
50-Day Moving Average | 1.83 |
20-Day Moving Average | 1.88 |
10-Day Moving Average | 1.83 |
Average True Range | 0.14 |
RSI (14) | 45.95 |
ADX | 24.3 |
+DI | 12.25 |
-DI | 20.00 |
Chandelier Exit (Long, 3 ATRs) | 1.99 |
Chandelier Exit (Short, 3 ATRs) | 2.04 |
Upper Bollinger Bands | 2.03 |
Lower Bollinger Band | 1.72 |
Percent B (%b) | 0.25 |
BandWidth | 16.24 |
MACD Line | -0.03 |
MACD Signal Line | 0.00 |
MACD Histogram | -0.0227 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.97 | ||||
Resistance 3 (R3) | 1.95 | 1.87 | 1.94 | ||
Resistance 2 (R2) | 1.87 | 1.83 | 1.88 | 1.93 | |
Resistance 1 (R1) | 1.84 | 1.81 | 1.86 | 1.86 | 1.92 |
Pivot Point | 1.76 | 1.76 | 1.77 | 1.77 | 1.76 |
Support 1 (S1) | 1.73 | 1.72 | 1.75 | 1.75 | 1.68 |
Support 2 (S2) | 1.65 | 1.70 | 1.66 | 1.67 | |
Support 3 (S3) | 1.62 | 1.65 | 1.66 | ||
Support 4 (S4) | 1.64 |